As in previous issues of EPLR, Issue 1/2019 tracks the latest legal and regulatory developments in the pharmaceutical sector. When it comes to developments in the industry, few offer as many opportunities as AI. With this in mind, the lead article of the first issue of the year tackles the legal challenges brought about these technological advances and offers practical advice on how companies should approach them.

With contributions on Brexit, new developments in Denmark and in the Ukraine, our Reports section is also required reading for those who want to keep up to date on crucial legislative and policy developments. The issue concludes with a fascinating case note on the Courts interpretation of Articles 11(2) and 21(3) of Directive 2001/83/EC concerning carve outs.